Jeon Seung-ho, CEO of Daewoong Pharmaceutical, "We Will Achieve New Drug Development Results" View original image


[Asia Economy Reporter Choi Dae-yeol] Jeon Seung-ho (photo), CEO of Daewoong Pharmaceutical, said on the 2nd, "Let us expand our global business and nurture future growth engines to move toward a grand vision."


At the opening ceremony held at the headquarters that day, CEO Jeon urged, "Despite last year's global economic recession and intensified competition, we maintained steady growth through Nabota's entry into major markets and increased performance across various businesses." His management policy for this year includes enhancing customer value, expanding global market entry, developing innovative new drugs through open collaboration, and fostering talent that leads challenges and change. He also emphasized the importance of ensuring excellent drug efficacy and safety as a pharmaceutical company and asked for efforts to guarantee the highest quality.


He stated, "This year will be a year to fully realize the results of new drug development that we have honed so far," adding, "Please strengthen capabilities so that various new drug pipelines, led by Pexuprazan?which is undergoing global clinical trials to enter the global gastroesophageal reflux disease treatment market worth nearly 40 trillion won?can be recognized as blockbusters in the global market."



He continued, "Through strategic open collaboration, we must further enhance our competitiveness in new drug development and secure diverse pipelines to create future value," and said, "Based on innovation in work methods that awaken a shift in mindset, challenge, and change, we will nurture global talent." He also quoted the proverb, 'Those who build walls and live within them will surely perish, and only those who constantly move will survive forever,' encouraging, "To continuously grow in an uncertain future, we must not be complacent with the present but innovate, always prepare, and take on challenges."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing